Eramol (formerly Eromol UK Ltd) is a UK-based CDMO specializing in bespoke clinical trial manufacturing services, founded by two Qualified Persons. The company provides end-to-end services including formulation development, primary manufacturing, clinical packaging, QP release, and global distribution from MHRA and HPRA-approved facilities, with a new sterile injectable site opening in early 2026.
Clinical trial manufacturing, IMP manufacturing, Formulation development, EU/UK QP release, EU/UK importation, Placebo manufacturing
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.